You've built a risk register, assigned impact scores, and color-coded everything by severity. Yet, when your auditor asks how you prioritized which risks to treat first, you're still pointing at a spreadsheet full of red-yellow-green cells, hoping that counts as quantitative analysis.
These myths persist because they're comfortable. Excel-based risk matrices feel scientific enough to satisfy ISO/IEC 27001 Clause 6.1.2's risk assessment requirements without forcing you to learn new tools. But comfort isn't the same as accuracy. When you're defending your risk treatment plan to a certification body or explaining control gaps to your board, "we used a 5x5 matrix" doesn't demonstrate the rigor that modern compliance frameworks expect.
Myth 1: Excel Is Sufficient for Monte Carlo Simulations
The Reality: Excel lacks native support for the statistical distributions that make risk modeling accurate. You can't easily inverse-sample a Poisson distribution in Excel without building custom VBA macros or installing third-party add-ins. The qpois function in R samples quartiles for occurrence rates directly, letting you model events that happen 36 times a year just as easily as events that happen once every five years. When your risk portfolio spans that range, you need tools built for statistical work, not spreadsheet workarounds.
The limitation hits hardest when you're modeling high-frequency events. If you're converting occurrence rates to percentage probabilities, your model breaks down at two or more occurrences per period. You end up either artificially shrinking your analysis window or accepting that your numbers don't reflect reality.
Myth 2: All Risk Distributions Are Created Equal
The Reality: The distribution you choose changes your results, sometimes dramatically. Lognormal distributions have long tails with extreme outliers that can skew your risk calculations in ways that don't match your actual exposure. The Modified PERT distribution handles uncertain estimates with a similar skew but constrains those long-tail values more realistically.
Consider harm estimation. You know the minimum loss might be $10,000, the most likely around $50,000, and the maximum $250,000. A lognormal distribution might occasionally spit out values that dwarf your maximum because of tail behavior. Modified PERT respects your boundaries while still accounting for uncertainty. When you're presenting risk treatment priorities to stakeholders who will question why you spent budget on Control A instead of Control B, you need to defend not just your numbers but the statistical reasoning behind them.
Myth 3: Simple Qualitative Matrices Meet ISO/IEC 27001 Requirements
The Reality: ISO/IEC 27001 Clause 6.1.2(c) requires you to "analyze the information security risks." Analysis means understanding likelihood and consequence in ways that inform decisions. A 5x5 heat map where "high likelihood" means "between 40% and 60%" doesn't give you the precision to compare two risks that both land in the same cell but have meaningfully different profiles.
Monte Carlo simulation runs 10,000 samples and calculates a mean of the results. That's not perfectionism; it's recognizing that risk isn't a single point estimate. When your auditor asks why you accepted Risk X but treated Risk Y, you need to show that your methodology distinguished between them in a defensible way. "They were both red on the matrix" doesn't cut it during surveillance audits.
Myth 4: Building Your Own Risk Model Is Too Complex
The Reality: The barrier to quantitative risk analysis isn't complexity; it's unfamiliarity. The R code to run a basic Monte Carlo simulation combining Poisson occurrence rates with Modified PERT harm estimates fits in a few dozen lines. You define your occurrence rate (lambda), your harm range (minimum, likely, maximum), and your confidence level. The replicate() function handles sampling, and a simple loop combines occurrence with consequence.
If writing code isn't your strength, open-source tools like RiskQuant exist specifically for this purpose. The point isn't that you must become an R programmer; it's that treating quantitative analysis as out of reach means you're limiting your risk treatment strategy based on tool comfort rather than analytical need.
Myth 5: Quantitative Analysis Doesn't Apply to Compliance-Driven Risks
The Reality: Compliance frameworks don't exempt you from understanding frequency and impact. SOC 2's CC3.2 (risk identification and assessment) and ISO/IEC 27001 Annex A Control 5.7 (threat intelligence) both expect you to evaluate risks in ways that support rational treatment decisions. Whether the risk originates from a threat actor or from regulatory change, you still need to know how often it might materialize and what the consequences look like.
Your risk treatment plan under ISO/IEC 27001 Clause 6.1.3 requires you to compare treatment options. If you can't quantify the reduction in expected loss from implementing a control, you're choosing controls based on intuition rather than evidence. That works until your certification auditor asks you to justify why you invested in DLP but deferred the SIEM upgrade.
What to Do Instead
Start by identifying which risks in your register would benefit from quantitative modeling. You don't need to model everything; focus on risks where the treatment decision isn't obvious or where stakeholders question your priorities.
For those risks, gather your estimates: occurrence rate (events per year), minimum harm, most likely harm, and maximum harm. If you don't have precise numbers, use ranges and document your assumptions. ISO/IEC 27001 Clause 7.5 (documented information) requires you to maintain evidence of your risk assessment process, and showing your statistical methodology strengthens that evidence.
Choose your tool based on your team's capabilities. If you have R or Python skills in-house, build a model that fits your specific risk scenarios. If not, evaluate RiskQuant or similar open-source projects that handle the statistical work while letting you focus on defining inputs.
Run your simulations and compare the results to your current risk register. Where do the quantitative results differ from your qualitative scores? Those gaps reveal where your intuition might be leading you astray or where your risk matrix categories are too broad to distinguish meaningfully different exposures.
When you present your risk treatment plan, lead with the analysis. Show the distribution of potential outcomes, explain why you chose specific controls based on their impact on expected loss, and demonstrate that your priorities follow from evidence rather than assumption. That's the rigor compliance frameworks expect, and it's what separates risk management from risk theater.
